Sexual Distress in Patients with Hidradenitis Suppurativa: A Cross-Sectional Study

Cuenca‐Barrales, Carlos; Ruiz‐Villaverde, Ricardo; Molina-Leyva, Alejandro

doi:10.3390/jcm8040532

Cited by 27 publications

(66 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Patients with HS also experience more sexual distress than a healthy population 25,29 . This impact seems to be higher for women with HS, 25,32 as occurs with psoriasis 46 . Some factors such as changes in body image may affect women more at this level, 47 since their arousal mechanisms and sexual function are more complex.…”

Section: Discussionmentioning

confidence: 99%

Sexual impairment in patients with hidradenitis suppurativa: a systematic review

Cuenca‐Barrales

Montero‐Vílchez

Szepietowski

et al. 2020

Acad Dermatol Venereol

Self Cite

View full text Add to dashboard Cite

Hidradenitis suppurativa (HS) can cause considerable impact on several aspects of quality of life. Sexuality is a central aspect of quality of life. In recent years, there has been an increase in the number of articles on HS and sexuality. To achieve our aim of synthesizing the available scientific evidence on HS and sexual health, we conducted a systematic review in February 2020. The clinical databases used included Medline and Embase. All types of epidemiological articles were included; reviews, guidelines, protocols, conference abstracts and case report articles were excluded. Eleven studies were included for review, representing 42 729 patients with HS. The most common study design was cross‐sectional with or without comparison group(s), conducted in an outpatient setting or through surveys. Prevalence of sexual dysfunction ranged between 51–62%, and in the case of erectile dysfunction, a specific kind of sexual dysfunction affecting penile erection, it ranged from between 52% and 60% of patients studied using validated questionnaires. Potential risk factors for sexual dysfunction among men and women were identified, mainly related to disease activity, symptoms and partners. Mood disorders like depression and anxiety appear to be associated with sexual dysfunction. Women were more affected by sexual distress. HS patients with sexual dysfunction had a decreased overall quality of life. With respect to treatment, surgery did not improve sexual function and there is no scientific evidence regarding medical treatments. Patients stated that they would like to treat their sexual problems with healthcare professionals. In conclusion, sexual and erectile dysfunction are common in HS patients, and negatively affect their quality of life. There are clinical factors potentially associated with this which should be identified and treated by dermatologists in the comprehensive care of HS patients. Prospective studies are needed to provide more scientific evidence on this unmet need.

show abstract

Section: Discussionmentioning

confidence: 99%

Sexual impairment in patients with hidradenitis suppurativa: a systematic review

Cuenca‐Barrales

Montero‐Vílchez

Szepietowski

et al. 2020

Acad Dermatol Venereol

Self Cite

View full text Add to dashboard Cite

show abstract

“…Furthermore, HS impairs patients’ mental health. It has been related to higher levels of depression and anxiety, worse quality of life, sexual dysfunction and a higher suicide risk [ 3 , 4 , 9 , 10 , 11 ] Moreover, it has direct consequences on social relationships and professional careers, such as higher absenteeism and unemployment levels [ 3 , 4 ]. For all these reasons, HS is a stigmatizing and disabling disease.…”

Section: Introductionmentioning

confidence: 99%

Quality of Life in Cohabitants of Patients with Hidradenitis Suppurativa: A Cross-sectional Study

Ramos-Alejos-Pita

Arias‐Santiago

Molina-Leyva

2020

IJERPH

Self Cite

View full text Add to dashboard Cite

Hidradenitis suppurativa (HS) is a chronic inflammatory disease that impairs patients’ physical and mental health. However, few studies have considered the consequences of HS on cohabitants. The aims of this study were to explore the impact of HS on the quality of life (QOL) of cohabitants and to assess potentially associated factors. A cross-sectional study was conducted and patients with HS and their cohabitants were invited to participate. Validated questionnaires were used to measure QOL, anxiety and depression, type D personality and sexual dysfunction. The clinical variables of patients and the demographic characteristics of cohabitants were also collected. Twenty-seven patients and 27 cohabitants were included for analysis. Patients and cohabitants presented significant QOL impairment. A direct association was found between the Dermatology Life Quality Index (DLQI) and the Familiar Dermatology Life Quality Index (FDLQI). DLQI scores were associated with the presence of negative affectivity, a trait typical of type D personality, as well as with cohabitants’ anxiety. FDLQI scores were associated with cohabitant anxiety and patient depression. Hidradenitis suppurativa damages quality of life in patients and cohabitants. Identifying potential psychological factors could help us to recognize at-risk patients and apply personalized treatments for them and their environment.

show abstract

“…Hidradenitis suppurativa (HS) is a chronic disease causing painful, malodorous nodules and abscesses that scar to form sinus tracts/tunnels. HS has a devastating impact on quality of life [1, 2], contributing to chronic pain [3], poor mental health [4], substance use disorder [5], impaired intimate relationships [6, 7], and suicide rates 2.4 times that of the general population [8]. While multiple HS treatment guidelines exist [9-13], paucity of high-quality evidence limits the strength of their recommendations.…”

Section: Introductionmentioning

confidence: 99%

Medical and Surgical Management of Hidradenitis Suppurativa: A Review of International Treatment Guidelines and Implementation in General Dermatology Practice

et al. 2020

View full text Add to dashboard Cite

Background: Hidradenitis suppurativa (HS) is a chronic painful skin disease that severely impairs patients' quality of life. While high-quality trials of HS therapies remain limited, medical knowledge of best treatment practices is rapidly evolving, leading to the recent publication of multiple international treatment guidelines for HS. Summary: This review compares international HS treatment guidelines, describes evidence for effectiveness of common and emerging HS therapies, and provides guidance for integrating evidence-based HS care into practice. Although over 50 medical and procedural treatments are mentioned across international HS guidelines, only adalimumab and infliximab have grade B/ weak recommendation or higher across all major guidelines. This review describes the appropriate patient selection and effectiveness of the most commonly used medical and procedural treatments for HS. It also includes recommendations for counseling, dosing, and duration of medical therapies as well as procedure videos for the practicing dermatologist.

show abstract

Sexual Distress in Patients with Hidradenitis Suppurativa: A Cross-Sectional Study

Cited by 27 publications

References 36 publications

Sexual impairment in patients with hidradenitis suppurativa: a systematic review

Sexual impairment in patients with hidradenitis suppurativa: a systematic review

Quality of Life in Cohabitants of Patients with Hidradenitis Suppurativa: A Cross-sectional Study

Medical and Surgical Management of Hidradenitis Suppurativa: A Review of International Treatment Guidelines and Implementation in General Dermatology Practice

Contact Info

Product

Resources

About